Recent Updates
Recently added Catalysts
STRO Positive Sentiment

15th Annual World ADC Conference – Presentations

Key Takeaway: The 15th Annual World ADC Conference showcased several key presentations by Sutro Biopharma. Notable topics included the development of dual-payload antibody drug conjugates, clinical updates on Luvelta, and preclinical safety studies for STRO-004. Experts also discussed leveraging cell-free protein synthesis to enhance ADC therapeutic indices. The event highlighted significant advancements in the field of antibody-drug conjugates.
Price reaction · baseline $42.1 (2024-11-06T15:29:00.000Z) · hit during market hours · clean, no other STRO news in the window
day 0 close · peak
-1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation on innovative dual-payload antibody drug conjugates.
  • Clinical updates on Luvelta targeting folate receptor.
  • Insights into preclinical safety and activity of STRO-004.
  • Advancements in cell-free protein synthesis for ADCs.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~13 mo
Low dilution risk
Lead asset
STRO-004
Phase 1 · Head and Neck Squamous Cell Carcinoma HNSCC

Full Press Release Details

[et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title author=”off” categories=”off” comments=”off” admin_label=”15th Annual World ADC Conference – Presentation” _builder_version=”4.23.4″ title_level=”h2″ title_text_color=”#0c71c3″ title_font_size=”28px” title_letter_spacing=”1px” title_line_height=”1.4em” meta_text_color=”#000000″ global_colors_info=”{}”][/et_pb_post_title][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
Development of Dual-Payload Antibody Drug Conjugates
Presenter: Daniel Calarese, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2024/11/STRO_Daniel-Calarese_World-ADC-2024_FINAL.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” global_colors_info=”{}”][/et_pb_button][et_pb_gallery gallery_ids=”16081,16082,16083,16084,16085,16086,16087,16088,16089,16090,16091,16092,16093,16094,16095,16096,16097,16098,16099,16100,16101,16102,16103,16104,16105,16106,16107,16108,16109,16110,16111,16112,16113,16114″ fullwidth=”on” _builder_version=”4.23.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” global_colors_info=”{}”][/et_pb_gallery][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
Clinical Update & Learnings for Luvelta Targeting Folate Receptor
Presenter: Hans-Peter Gerber, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2024/11/HP_Luvelta_ADC-World_11-07-2025_FINAL.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_button][et_pb_gallery gallery_ids=”16270,16271,16272,16273,16274,16275,16276,16277,16278,16279,16280,16281,16282,16283,16284,16285,16286,16287,16288,16289,16290,16291,16292,16293,16294,16295,16296,16297,16298,16299″ fullwidth=”on” _builder_version=”4.23.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″][/et_pb_gallery][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
Preclinical Safety & Activity of STRO-004, a Tissue Factor ADC
Presenter: Alice Yam, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2024/11/STRO_Alice-Yam_World-ADC-2024_FINAL.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” global_colors_info=”{}”][/et_pb_button][et_pb_gallery gallery_ids=”16153,16154,16155,16156,16157,16158,16159,16160,16161,16162,16163,16164,16165,16166,16167,16168,16169,16170,16171,16172,16173″ fullwidth=”on” _builder_version=”4.23.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” global_colors_info=”{}”][/et_pb_gallery][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
Leveraging Cell-Free Protein Synthesis for Site- Specific Conjugation to Enhance ADC Therapeutic Index
Presenter: Gang Yin, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2024/11/STRO_Gang-Yin_World-ADC-2024_FINAL.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” global_colors_info=”{}”][/et_pb_button][et_pb_gallery gallery_ids=”16206,16207,16208,16209,16210,16211,16212,16213,16214,16215,16216,16217,16218,16219,16220,16221,16222,16223,16224,16225,16226,16227,16228,16229,16230,16231,16232″ fullwidth=”on” _builder_version=”4.23.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” global_colors_info=”{}”][/et_pb_gallery][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.17.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.23.4″ _module_preset=”default” text_font_size=”19px” global_colors_info=”{}”]
Optimizing High DAR & Dual Payload ADCs: Discovery of Hydrophilic β-glu Cleavable Linker Payloads for Superior Efficacy and Safety
Presenter: Krishna Bajjuri, Ph.D.
[/et_pb_text][et_pb_button button_url=”https://www.sutrobio.com/wp-content/uploads/2024/11/STRO_Krishna-Bajjuri_World-ADC-2024_FINAL.pdf” url_new_window=”on” button_text=”Presentation” button_alignment=”left” admin_label=”Presentation – Button” _builder_version=”4.23.4″ _module_preset=”default” custom_button=”on” button_text_size=”18px” button_text_color=”#0C71C3″ button_bg_color=”#FFFFFF” button_border_width=”1px” button_border_color=”#0C71C3″ button_border_radius=”3px” button_icon=”||divi||400″ button_icon_color=”#0C71C3″ button_on_hover=”off” global_colors_info=”{}”][/et_pb_button][et_pb_gallery gallery_ids=”16235,16236,16237,16238,16239,16240,16241,16242,16243,16244,16245,16246,16247,16248,16249,16250,16251,16252,16253,16254,16255,16256,16257,16258,16259,16260″ fullwidth=”on” _builder_version=”4.23.4″ _module_preset=”default” pagination_text_color=”#FFFFFF” module_alignment=”center” global_colors_info=”{}”][/et_pb_gallery][et_pb_divider color=”#0badbc” divider_weight=”2px” _builder_version=”4.16″ global_colors_info=”{}”][/et_pb_divider][/et_pb_column][/et_pb_row][/et_pb_section]

Frequently Asked Questions

What was presented at the World ADC Conference?

Key presentations included dual-payload ADCs, clinical updates on Luvelta, and STRO-004 safety studies.

Who presented at the conference?

Presenters included Daniel Calarese, Hans-Peter Gerber, Alice Yam, Gang Yin, and Krishna Bajjuri.

What is STRO-004?

STRO-004 is a tissue factor antibody-drug conjugate discussed for its preclinical safety and activity.

What advancements were discussed in ADC technology?

Advancements included leveraging cell-free protein synthesis for enhancing ADC therapeutic indices.

Last updated: Nov 6, 2024